Chorioangioma of the placenta is a common benign vascular tumour of the placenta consisting of blood vessels and stroma. Most of these tumours are small and have no adverse impact on the fetus. Large tumours are associated with complications affecting mother and the fetus which may cause intrauterine fetal death. Chorioangiomas probably act as peripheral shunts between arteries and veins (arteriovenous shunts) leading to progressive heart failure of the fetus. Prenatal diagnosis is achieved by ultrasonography and Doppler studies will confirm the highly vascular nature of the mass. As the tumour is associated with unfavourable effects on the mother and fetus like polyhydramnios, prematurity, toxaemia, hydrops and fetal heart failure pregnancy needs to have regular surveillance to detect and manage complications early. A case of giant placental chorioangioma in a primigravida associated with intrauterine fetal death at 30 weeks of gestation is reported.
INTRODUCTION
Giant placental chorioangioma are associated with a high prevalence of pregnancy complications and a poor perinatal outcome. 1 The tumour may be located accidentally during routine antenatal scan. The sonographic appearance of a chorioangioma is that of a solid or complex mass on the fetal surface of the placenta .Mostly located underneath the chorionic plate near the insertion of the umbilical cord and often protruding into the amniotic cavity. 2 Three histological patterns of chorioangiomas described in literature are angiomatous, cellular and degenerate. The angiomatous is the most common with numerous small areas of endothelial tissue, capillaries and blood vessels surrounded by placental stroma. The cellular pattern has abundant endothelial cells within a loose stroma. The degenerate pattern has calcification, necrosis or hyalinization.
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CASE REPORT
Twenty seven years primigravida was admitted with history of vaginal bleeding at 25 weeks in Nizwa referral hospital. A routine ultrasound examination revealed a live fetus with normal liquor estimation. No fetal structural anomalies were detected and there was no evidence of hydrops fetalis. Placenta was in the upper anterior segment and a large, subchorionic, well circumscribed mass, hypoechoiec measuring 5.97 cm x 8.55 cm was observed protruding into the amniotic cavity.This mass was arising from the fetal surface of the placenta, marginally placed, with different echogenicity from the rest of the placenta. Color Doppler was consistent with a highly vascularized mass. An impression of placental tumour (haemangioma) was made ( Figure 1 ). She was vitally stable with blood pressure 120/70mmHg, pulse 80 beats/minute, and respiratory rate 18 breaths/ minute. Her investigations showed VDRL non-reactive, sickling negative, blood group O Rh positive, Hb 11.4g/ dl and platelets 231K/ul.Coagulation profile, renal and liver function tests were within normal limits. No history of diabetes or hypertension was noted. She was admitted for rest and further evaluation of this mass. She received dexamethasone for improvement of fetal lung maturity. Patient remained vitally stable during her stay in the hospital with no complaints of vaginal bleeding. Thereafter she followed in the outpatient department in the high risk pregnancy clinic. Follow up ultrasound and umbilical artery Doppler studies were normal. At 30 weeks she reported to accident and emergency department with increasing labour pains and history of loss of fetal movements since three days. Ultrasound examination confirmed intrauterine fetal death with mild fetal hydrops. Placental examination revealed the same hypoechoic mass with the same measurements. On examination she was in active labour with cervical dilatation of 3 cm and bulging membranes. She laboured for five hours and delivered a macerated still birth male fetus of 1100gms. No obvious fetal anomaly was noted. Placenta and the mass with membranes delivered after 20 minutes as the cord got severed during the expulsion of this large placental mass. Placenta and the mass together weighed 1100 gms. The mass weighed 600 gms whereas the placenta weighed lesser, 500 gms. The mass was purplish red in colour with glistening, bosselated outer surface, soft and spongy in consistency (Figure 2 ). The specimen was sent for histopathologic examination. Her postnatal period was uneventful. She was discharged two days later and follow up checkup two weeks later was unremarkable.
The histopathological report was released as: 
DISCUSSION
Chorioangioma is the most common benign tumour of the placenta and is thought to be either an angioma or hamartoma derived from primitive chorionic mesenchyme. 4 Majority are single, small, encapsulated, intraplacental vascular tumours. Ghourab, 5 reported that vascular hypoechogenic tumours are associated with higher incidence of pregnancy complications as compared to avascular hyperechogenic ones. However large chorioangiomas are rare and complications may not always ensue. In our case the mass was large, highly vascular and fetal death with hydrops may be attributed to this as no other gross fetal anomaly or any maternal medical condition like diabetes or hypertension was detected.
The main fetal risks are non-immune hydrops, cardiomegaly, congestive cardiac failure, anaemia, thrombocytopaenia, consumptive coagulopathy, prematurity and sudden infant death. Fetal hydrops was the only finding observed in our case. The main maternal risks associated with these tumours are polyhydramnios, antepartum haemorrhage, toxaemia of pregnancy and preterm delivery. 6 A large placental chorioangioma may even cause obstructed vaginal delivery as was observed in our case where there was delay in delivery of the placenta. Sudden intrauterine death can be caused by fetal congestive cardiac failure with cardiac enlargement caused by arteriovenous shunt through a placental chorioangioma causing chronic fetal hypoxia secondary to insufficient placental function or anemia. Anaemia may be secondary to blood sequestration in the tumour or fetomaternal haemorrhage. 7 The other reason for sudden fetal death may be bleeding from ruptured sinusoids within the tumour. 8 The prognosis is poor if fetal hydrops develops. Perinatal death rate of 30-40% has been reported due to microangiopathic hemolytic anemia, thrombocytopaenia and hydrops. 9 Colour doppler imaging not only helps to differentiate chorioangioma from other lesions like degenerating fibroid, placental teratoma, vanishing twin, placental haematoma but also helps in perinatal follow up of these cases. 10 Till now there are no studies to demonstrate the sensitivity and specificity of magnetic resonance imaging in distinguishing chorioangioma from other placental lesions. 11 Chorioangioma have no malignant potential. Prenatal treatment by ultrasound guided interstitial laser therapy is one of the interventions to prevent complications of chorioangioma besides the use of suture ligation, bipolar cautery, microcoil embolisation and alcohol injection described in literature. 12 Recent literature shows ongoing studies illustrating complexity in placental tissue growth factors, cytokines, angiogenic and anti-angiogenic factors to be responsible for multiple recurrent chorioangiomas. 13 
CONCLUSIONS
A routine antenatal ultrasound scan should not only screen the placental location but also the placental composition to exclude the presence of a large chorioangioma. As this tumour is associated with unfavorable effects on mother and fetus, pregnancy needs to have regular surveillance which includes serial ultrasound, Doppler studies and fetal echocardiography to detect and manage complications early and effectively for safe maternal and fetal outcome.
